$0.1206
N/A
Last update: Oct 22, 1:23 PM
PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc. (MDXXF) Stock Price, Quote, News & History
MDXXFOTCQB
PharmAla Biotech will supply GMP LaNeo MDMA to Mt. Sinai Health System for clinical research, advancing therapy for neurological disorders.
You can purchase shares of PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc. (OTCQB:MDXXF) through any online brokerage.
There are no as such competitors for PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc..
There is no analysis for PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc. to provide a consensus price target.
The stock price for PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc. (OTCQB: MDXXF) is $0.120575 last updated October 22, 2026 at 1:23 PM EDT.
There are no upcoming dividends for PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc..
PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc..
PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.
Pharmala Biotech Holdings Inc is a Canadian Biotechnology company focused on the development, manufacture and sales of MDMA and MDXX class molecules in service to the burgeoning clinical research community and growing commercial use cases in select...
